{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"16.33","value":"33.6"},{"groupId":"OG001","spread":"23.58","value":"38.4"},{"groupId":"OG002","spread":"36.54","value":"41.6"},{"groupId":"OG003","spread":"28.78","value":"51.8"},{"groupId":"OG004","spread":"26.78","value":"69.6"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"22"},{"groupId":"OG003","value":"17"},{"groupId":"OG004","value":"4"}],"units":"Participants"}],"description":"From day 15 by dose with schedule: MWF every week","dispersionType":"Standard Deviation","groups":[{"description":"Panobinostat was administered orally, once-a-day, on Monday-Wednesday-Friday (MWF)","id":"OG000","title":"20 mg"},{"description":"Panobinostat was administered orally, once-a-day, on Monday-Wednesday-Friday (MWF)","id":"OG001","title":"30 mg"},{"description":"Panobinostat was administered orally, once-a-day, on Monday-Wednesday-Friday (MWF)","id":"OG002","title":"40 mg"},{"description":"Panobinostat was administered orally, once-a-day, on Monday-Wednesday-Friday (MWF)","id":"OG003","title":"60 mg"},{"description":"Panobinostat was administered orally, once-a-day, on Monday-Wednesday-Friday (MWF)","id":"OG004","title":"80 mg"}],"paramType":"MEAN","populationDescription":"Pharmacokinetic set","reportingStatus":"POSTED","timeFrame":"Day 15","title":"Maximum Plasma Concentration of Panobinostat After Multiple Doses in Arm 1 on Day 15","type":"SECONDARY","unitOfMeasure":"ng/mL"}